Qlucore AB (publ) (ST:NOVKAN) — Market Cap & Net Worth

$326.04K USD · Skr3.03 Million SEK · Rank #31072

Market Cap & Net Worth: Qlucore AB (publ) (NOVKAN)

Qlucore AB (publ) (ST:NOVKAN) has a market capitalization of $326.04K (Skr3.03 Million) as of July 22, 2026. Listed on the ST stock exchange, this USA-based company holds position #31072 globally and #6200 in its home market, demonstrating a -54.46% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Qlucore AB (publ)'s stock price Skr0.03 by its total outstanding shares 121186228 (121.19 Million). See NOVKAN capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.

Qlucore AB (publ) Market Cap History: 2025 to 2026

Qlucore AB (publ)'s market capitalization history from 2025 to 2026. Data shows growth from $2.04 Million to $326.04K (0.00% CAGR).

Qlucore AB (publ) Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Qlucore AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
No financial ratio data available

Competitor Companies of NOVKAN by Market Capitalization

Companies near Qlucore AB (publ) in the global market cap rankings as of July 22, 2026.

Key companies related to Qlucore AB (publ) by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
Argen-X (BR:ARGX): Ranked #541 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
UCB SA (BR:UCB): Ranked #560 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#222	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$110.45 Billion	$480.50
#424	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$64.60 Billion	$672.15
#541	Argen-X	BR:ARGX	$49.55 Billion	€753.60
#560	UCB SA	BR:UCB	$47.34 Billion	€238.00

Qlucore AB (publ) Historical Marketcap From 2025 to 2026

Between 2025 and today, Qlucore AB (publ)'s market cap moved from $2.04 Million to $ 326.04K, with a yearly change of 0.00%.

Year	Market Cap	Change (%)
2026	Skr326.04K	-84.02%
2025	Skr2.04 Million	--

End of Day Market Cap According to Different Sources

On Jul 21st, 2026 the market cap of Qlucore AB (publ) was reported to be:

Source	Market Cap
Yahoo Finance	$326.04K USD
MoneyControl	$326.04K USD
MarketWatch	$326.04K USD
marketcap.company	$326.04K USD
Reuters	$326.04K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Qlucore AB (publ)

ST:NOVKAN USA Biotechnology

Market Cap

$326.04K

Skr3.03 Million SEK

Market Cap Rank

#31072 Global

#6200 in USA

Share Price

Skr0.03

Change (1 day)

-43.95%

52-Week Range

Skr0.03 - Skr0.23

All Time High

Skr0.23